Current State and Further Development of Animal Models of Serious Infections Caused by Acinetobacter Baumannii and Pseudomonas Aeruginosa

U.S. Food and Drug Administration. 03/17/2017 This web page provides information, documents, and presentations from a meeting on March 1, 2017, to facilitate the development of narrow-spectrum antibacterial drugs, such as those that are active against only a single species of bacteria that may not occur frequently. Acinetobacter baumannii and Pseudomonas aeruginosa are Priority 1 (Critical) pathogens on the World Health Organization (WHO) priority pathogens list. Animal models of infection may be useful to explore the activity of a candidate antibacterial drug and may help to predict whether the drug will be efficacious in humans. (Text)

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 6, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news